Here is a brief preview of this blast: DarioHealth announced a partnership with Vitality Group to integrate Dario digital therapeutics for chronic conditions into Vitality’s wellness solution platform. According to Dario, the partnership is intended to accelerate penetration into the self-insured employer US market. Below, FENIX provides insight into the Dario/Vitality partnership as well as potential implications to Livongo and Onduo.
About The Author
Matthew Maryniak
President of Fenix Group International
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.